BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6434122)

  • 1. Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.
    Allan SG; Cornbleet MA; Warrington PS; Golland IM; Leonard RC; Smyth JN
    Br Med J (Clin Res Ed); 1984 Oct; 289(6449):878-9. PubMed ID: 6434122
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology.
    Rhinehart SN; Dugan WM; Parashos PJ; Triplett WC; Minnick DJ; Fry MW
    Prog Clin Biol Res; 1986; 216():407-16. PubMed ID: 3523534
    [No Abstract]   [Full Text] [Related]  

  • 4. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
    Tsavaris NB
    J Pain Symptom Manage; 1992 Nov; 7(8):440-2. PubMed ID: 1287105
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
    Strum SB; McDermed JE; Liponi DF
    J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis].
    Umehara H; Sawamura N; Takahashi S; Kusano H; Yokoyama S; Suemasu K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1996-8. PubMed ID: 3010886
    [No Abstract]   [Full Text] [Related]  

  • 9. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.
    Grunberg SM; Akerley WL; Krailo MD; Johnson KB; Baker CR; Cariffe PA
    Cancer Invest; 1986; 4(5):379-85. PubMed ID: 3801953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
    Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
    Cognetti F; Carlini P; PinnarĂ² P; Ruggeri EM; Caporali C
    Oncology; 1986; 43(5):292-4. PubMed ID: 3763123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine.
    al-Idrissi HY; Ibrahim EM; Abdullah KA; Ababtain WA; Boukhary HA; Macaulay HM
    Br J Cancer; 1988 Mar; 57(3):308-12. PubMed ID: 3281702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
    Nagai H; Suga S; Horiuchi Y; Kyokane K; Miwa Y; Aoki Y; Yasue K; Noro T; Kamikawa R; Ninomiya E
    Gan No Rinsho; 1990 Jun; 36(7):791-6. PubMed ID: 2113110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy.
    Ibrahim EM; Al-Idrissi HY; Ibrahim A; Absood G; Al-Dossary E; Al-Jammaa A; Al-Ethan S; Eliopoulos A
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):283-8. PubMed ID: 3519233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis.
    Akhtar SS; Bano ZA; Bhat GM; Bhat MA
    Oncology; 1991; 48(3):226-9. PubMed ID: 2023702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs.
    Cunningham D; Soukop M; Gilchrist NL; Forrest GJ; Hepplestone A; Calder IT; McArdle CS; Hutcheon AW; Kaye SB
    Br Med J (Clin Res Ed); 1985 Feb; 290(6468):604-5. PubMed ID: 3918691
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a combination antiemetic regimen including iv high-dose metoclopramide, dexamethasone, and diphenhydramine in cisplatin-based chemotherapy regimens.
    Rosell R; Abad-Esteve A; Ribas-Mundo M; Moreno I
    Cancer Treat Rep; 1985; 69(7-8):909-10. PubMed ID: 4040428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.